Profiles Header - Harvard Catalyst Profiles Header – Harvard Catalyst

Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Stan Neil Finkelstein, M.D.

Title
Institution
Department
Address
Phone
Other Positions
Title
Institution
Department

Mentoring
Examining the Role of Diagnostics in reducing the Burden of HIV/AIDS in Resource-Limited Developing Countries
International, 09/01/09 - 05/30/10
Clinical Pathway Development For Acute Axial Low Back Pain
Summer, 06/07/12 - 08/17/12

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Majumder MS, Brownstein JS, Finkelstein SN, Larson RC, Bourouiba L. Nosocomial amplification of MERS-coronavirus in South Korea, 2015. Trans R Soc Trop Med Hyg. 2017 06 01; 111(6):261-269. PMID: 29044371.
    View in: PubMed
  2. Hashmi S, D'Ambrosio L, Diamond DV, Jalali MS, Finkelstein SN, Larson RC. Preventive behaviors and perceptions of influenza vaccination among a university student population. J Public Health (Oxf). 2016 12 02; 38(4):739-745. PMID: 28158761.
    View in: PubMed
  3. Krupat E, Dienstag JL, Kester WC, Finkelstein SN. Medical Students Who Pursue a Joint MD/MBA Degree: Who Are They and Where Are They Heading? Eval Health Prof. 2017 06; 40(2):203-218. PMID: 26801747.
    View in: PubMed
  4. Leveson N, Samost A, Dekker S, Finkelstein S, Raman J. A Systems Approach to Analyzing and Preventing Hospital Adverse Events. J Patient Saf. 2016 Jan 11. PMID: 26756729.
    View in: PubMed
  5. Hashmi S, D'Ambrosio L, Diamond DV, Jalali MS, Finkelstein SN, Larson RC. Preventive behaviors and perceptions of influenza vaccination among a university student population. J Public Health (Oxf). 2016 Jan 06. PMID: 26744036.
    View in: PubMed
  6. Pereira RD, Salgado CM, Dejam A, Reti SR, Vieira SM, Sousa JM, Celi LA, Finkelstein SN. Fuzzy Modeling to Predict Severely Depressed Left Ventricular Ejection Fraction following Admission to the Intensive Care Unit Using Clinical Physiology. ScientificWorldJournal. 2015; 2015:212703. PMID: 26345130; PMCID: PMC4542022.
  7. Fialho AS, Celi LA, Cismondi F, Vieira SM, Reti SR, Sousa JM, Finkelstein SN. Disease-based modeling to predict fluid response in intensive care units. Methods Inf Med. 2013; 52(6):494-502. PMID: 23986268.
    View in: PubMed
  8. Cismondi F, Fialho AS, Vieira SM, Reti SR, Sousa JM, Finkelstein SN. Missing data in medical databases: impute, delete or classify? Artif Intell Med. 2013 May; 58(1):63-72. PMID: 23428358.
    View in: PubMed
  9. Cismondi F, Celi LA, Fialho AS, Vieira SM, Reti SR, Sousa JM, Finkelstein SN. Reducing unnecessary lab testing in the ICU with artificial intelligence. Int J Med Inform. 2013 May; 82(5):345-58. PMID: 23273628.
    View in: PubMed
  10. Finkelstein S, Prakash S, Nigmatulina K, McDevitt J, Larson R. A home toolkit for primary prevention of influenza by individuals and families. Disaster Med Public Health Prep. 2011 Dec; 5(4):266-71. PMID: 22146665.
    View in: PubMed
  11. Finkelstein SN, Hedberg KJ, Hopkins JA, Hashmi S, Larson RC. Vaccine availability in the United States during the 2009 H1N1 outbreak. Am J Disaster Med. 2011 Jan-Feb; 6(1):23-30. PMID: 21466026.
    View in: PubMed
  12. Cady R, Finkelstein S, Kelly A. A telehealth nursing intervention reduces hospitalizations in children with complex health conditions. J Telemed Telecare. 2009; 15(6):317-20. PMID: 19720770.
    View in: PubMed
  13. Goulart BH, Clark JW, Pien HH, Roberts TG, Finkelstein SN, Chabner BA. Trends in the use and role of biomarkers in phase I oncology trials. Clin Cancer Res. 2007 Nov 15; 13(22 Pt 1):6719-26. PMID: 18006773.
    View in: PubMed
  14. Schachter AD, Ramoni MF, Baio G, Roberts TG, Finkelstein SN. Economic evaluation of a Bayesian model to predict late-phase success of new chemical entities. Value Health. 2007 Sep-Oct; 10(5):377-85. PMID: 17888102.
    View in: PubMed
  15. Huse DM, von Mehren M, Lenhart G, Joensuu H, Blanke C, Feng W, Finkelstein S, Demetri G. Cost effectiveness of imatinib mesylate in the treatment of advanced gastrointestinal stromal tumours. Clin Drug Investig. 2007; 27(2):85-93. PMID: 17217313.
    View in: PubMed
  16. Stallings SC, Huse D, Finkelstein SN, Crown WH, Witt WP, Maguire J, Hiller AJ, Sinskey AJ, Ginsburg GS. A framework to evaluate the economic impact of pharmacogenomics. Pharmacogenomics. 2006 Sep; 7(6):853-62. PMID: 16981846.
    View in: PubMed
  17. Radley DC, Finkelstein SN, Stafford RS. Off-label prescribing among office-based physicians. Arch Intern Med. 2006 May 08; 166(9):1021-6. PMID: 16682577.
    View in: PubMed
  18. Lyman GH, Berndt ER, Kallich JD, Erder MH, Crown WH, Long SR, Lee H, Song X, Finkelstein SN. The economic burden of anemia in cancer patients receiving chemotherapy. Value Health. 2005 Mar-Apr; 8(2):149-56. PMID: 15804323.
    View in: PubMed
  19. Pransky GS, Berndt E, Finkelstein SN, Verma S, Agrawal A. Performance decrements resulting from illness in the workplace: the effect of headaches. J Occup Environ Med. 2005 Jan; 47(1):34-40. PMID: 15643157.
    View in: PubMed
  20. Roberts TG, Goulart BH, Squitieri L, Stallings SC, Halpern EF, Chabner BA, Gazelle GS, Finkelstein SN, Clark JW. Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials. JAMA. 2004 Nov 03; 292(17):2130-40. PMID: 15523074.
    View in: PubMed
  21. Ozminkowski RJ, Marder WD, Hawkins K, Wang S, Stallings SC, Finkelstein SN, Sinskey AJ, Wierz D. The use of disease-modifying new drugs for multiple sclerosis treatment in private-sector health plans. Clin Ther. 2004 Aug; 26(8):1341-54. PMID: 15476915.
    View in: PubMed
  22. Roberts TG, Goulart BH, Stallings SC, Squitieri L, Chabner BA, Finkelstein SN, Clark JW. Analysis of over 2,400 modern phase I cancer trials: Composition, outcomes, and use of surrogate endpoints. J Clin Oncol. 2004 Jul 15; 22(14_suppl):2084. PMID: 28015680.
    View in: PubMed
  23. Weilburg JB, Stafford RS, O'Leary KM, Meigs JB, Finkelstein SN. Costs of antidepressant medications associated with inadequate treatment. Am J Manag Care. 2004 Jun; 10(6):357-65. PMID: 15209479.
    View in: PubMed
  24. Pomerantz JM, Finkelstein SN, Berndt ER, Poret AW, Walker LE, Alber RC, Kadiyam V, Das M, Boss DT, Ebert TH. Prescriber intent, off-label usage, and early discontinuation of antidepressants: a retrospective physician survey and data analysis. J Clin Psychiatry. 2004 Mar; 65(3):395-404. PMID: 15096080.
    View in: PubMed
  25. Russell JM, Hawkins K, Ozminkowski RJ, Orsini L, Crown WH, Kennedy S, Finkelstein S, Berndt E, Rush AJ. The cost consequences of treatment-resistant depression. J Clin Psychiatry. 2004 Mar; 65(3):341-7. PMID: 15096073.
    View in: PubMed
  26. Stafford RS, Furberg CD, Finkelstein SN, Cockburn IM, Alehegn T, Ma J. Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002. JAMA. 2004 Jan 07; 291(1):54-62. PMID: 14709576.
    View in: PubMed
  27. Crown WH, Berndt ER, Baser O, Finkelstein SN, Witt WP, Maguire J, Haver KE. Benefit plan design and prescription drug utilization among asthmatics: do patient copayments matter? Front Health Policy Res. 2004; 7:95-127. PMID: 15612337.
    View in: PubMed
  28. Ma J, Stafford RS, Cockburn IM, Finkelstein SN. A statistical analysis of the magnitude and composition of drug promotion in the United States in 1998. Clin Ther. 2003 May; 25(5):1503-17. PMID: 12867225.
    View in: PubMed
  29. Stafford RS, Ma J, Finkelstein SN, Haver K, Cockburn I. National trends in asthma visits and asthma pharmacotherapy, 1978-2002. J Allergy Clin Immunol. 2003 Apr; 111(4):729-35. PMID: 12704350.
    View in: PubMed
  30. Crown WH, Finkelstein S, Berndt ER, Ling D, Poret AW, Rush AJ, Russell JM. The impact of treatment-resistant depression on health care utilization and costs. J Clin Psychiatry. 2002 Nov; 63(11):963-71. PMID: 12444808.
    View in: PubMed
  31. Wan GJ, Crown WH, Berndt ER, Finkelstein SN, Ling D. Healthcare expenditure in patients treated with venlafaxine or selective serotonin reuptake inhibitors for depression and anxiety. Int J Clin Pract. 2002 Jul-Aug; 56(6):434-9. PMID: 12166541.
    View in: PubMed
  32. Wan GJ, Crown WH, Berndt ER, Finkelstein SN, Ling D. Treatment costs of venlafaxine and selective serotonin-reuptake inhibitors for depression and anxiety. Manag Care Interface. 2002 Jun; 15(6):24-30. PMID: 12087603.
    View in: PubMed
  33. Stafford RS, MacDonald EA, Finkelstein SN. National Patterns of Medication Treatment for Depression, 1987 to 2001. Prim Care Companion J Clin Psychiatry. 2001 Dec; 3(6):232-235. PMID: 15014590.
    View in: PubMed
  34. Berndt ER, Bailit HL, Keller MB, Verner JC, Finkelstein SN. Health care use and at-work productivity among employees with mental disorders. Health Aff (Millwood). 2000 Jul-Aug; 19(4):244-56. PMID: 10916980.
    View in: PubMed
  35. Berndt ER, Koran LM, Finkelstein SN, Gelenberg AJ, Kornstein SG, Miller IM, Thase ME, Trapp GA, Keller MB. Lost human capital from early-onset chronic depression. Am J Psychiatry. 2000 Jun; 157(6):940-7. PMID: 10831474.
    View in: PubMed
  36. Cremieux PY, Finkelstein SN, Berndt ER, Crawford J, Slavin MB. Cost effectiveness, quality-adjusted life-years and supportive care. Recombinant human erythropoietin as a treatment of cancer-associated anaemia. Pharmacoeconomics. 1999 Nov; 16(5 Pt 1):459-72. PMID: 10662393.
    View in: PubMed
  37. Cockburn IM, Bailit HL, Berndt ER, Finkelstein SN. Loss of work productivity due to illness and medical treatment. J Occup Environ Med. 1999 Nov; 41(11):948-53. PMID: 10570499.
    View in: PubMed
  38. Greenberg PE, Sisitsky T, Kessler RC, Finkelstein SN, Berndt ER, Davidson JR, Ballenger JC, Fyer AJ. The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry. 1999 Jul; 60(7):427-35. PMID: 10453795.
    View in: PubMed
  39. Cockburn IM, Bailit HL, Berndt ER, Finkelstein SN. When antihistamines go to work. Bus Health. 1999 Mar; 17(3):49-50. PMID: 10387170.
    View in: PubMed
  40. Berndt ER, Finkelstein SN, Greenberg PE, Howland RH, Keith A, Rush AJ, Russell J, Keller MB. Workplace performance effects from chronic depression and its treatment. J Health Econ. 1998 Oct; 17(5):511-35. PMID: 10185510.
    View in: PubMed
  41. Finkelstein SN, Huber SL, Greenberg PE. Comment: cost comparison of recombinant human erythropoietin and blood transfusion in cancer chemotherapy-induced anemia. Ann Pharmacother. 1997 Sep; 31(9):1094-5. PMID: 9296258.
    View in: PubMed
  42. Finkelstein SN, Berndt ER, Greenberg PE, Parsley RA, Russell JM, Keller MB. Improvement in subjective work performance after treatment of chronic depression: some preliminary results. Chronic Depression Study Group. Psychopharmacol Bull. 1996; 32(1):33-40. PMID: 8927672.
    View in: PubMed
  43. Greenberg PE, Finkelstein SN, Berndt ER. Calculating the workplace cost of chronic disease. Bus Health. 1995 Sep; 13(9):27-8, 30. PMID: 10164773.
    View in: PubMed
  44. Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER. Depression: a neglected major illness. J Clin Psychiatry. 1993 Nov; 54(11):419-24. PMID: 8270584.
    View in: PubMed
  45. Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER. The economic burden of depression in 1990. J Clin Psychiatry. 1993 Nov; 54(11):405-18. PMID: 8270583.
    View in: PubMed
  46. Finkelstein SN, Sapolsky HM. Controlling post-transfusion hepatitis: a proposal to publicize hepatitis rates of transfusion facilities. Am J Law Med. 1979; 5(1):1-9. PMID: 495608.
    View in: PubMed
  47. Sapolsky HM, Finkelstein SN. Blood policy revisited--a new look at "The Gift Relationship" Public Interest. 1977; (46):Unknown. PMID: 11662458.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Finkelstein's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (251)
Explore
_
Co-Authors (16)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Tool Page Footer - Harvard Catalyst Tool Page Footer – Harvard Catalyst
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.